[Congressional Record Volume 144, Number 78 (Tuesday, June 16, 1998)]
[House]
[Pages H4612-H4613]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
RETINAL DEGENERATIVE DISEASES
The SPEAKER pro tempore. Under a previous order of the House, the
gentlewoman from Florida (Ms. Ros-Lehtinen) is recognized for 5
minutes.
Ms. ROS-LEHTINEN. The gift of sight, Mr. Speaker, is one of our most
precious. For those of us who are fortunate to have healthy eyesight,
we often fail to recognize that there are those who suffer from
debilitating diseases that impair their vision and that oftentimes may
lead to complete blindness.
Retinal degenerative diseases are a group of diseases that affect the
eye's innermost layer. They are inherited, the hereditary pattern
varying from family to family.
The most common forms of the diseases are macular degeneration, which
is the leading cause of blindness among seniors, retinitis pigmentosa,
and Usher's syndrome.
Retinitis pigmentosa is an inherited disease that is usually
diagnosed at childhood and is characterized by an increasing loss of
peripheral vision. Usher's syndrome is also inherited and is
accompanied by varying degrees of deafness and the development of
retinitis pigmentosa. Macular degeneration is thought to be caused by a
combination of genetic and environmental factors and is characterized
by a loss of central vision.
These diseases can be detected in routine eye exams; however, they
are fairly difficult to diagnose in their early stages. Retinal
degenerative diseases cause a loss of vision due to loss of light-
sensing photoreceptor cells in the retina. They are responsible for the
loss of sight of over 6 million Americans across our country. These
diseases unfortunately have no treatment and no cure.
Last Wednesday, along with the Foundation Fighting Blindness and a
very special family from my congressional district, the Lidsky family,
we held a congressional briefing on retinal degenerative diseases.
Three of the four Lidsky children, and they are the children of Carlos
and Betty Lidsky, have been affected by retinal degenerative diseases.
One of these wonderful children, Isaac, spoke at this briefing and
detailed to us how he has been affected by this disease. Isaac, who
aspires to be an attorney just like his father one day soon, has big
dreams. One of them is to find a cure for this disease that is
responsible for slowly taking away his eyesight.
Isaac and his sisters, Doria and Ilana, who also have this challenge,
reminded us that this disease has overwhelming effects on the lives of
those who are afflicted. He also reminded us about the bravery and the
perseverance of the human spirit. He is not letting this disease
conquer his dreams nor his hopes of someday very soon finding a cure.
[[Page H4613]]
My colleagues and I also had the opportunity to meet Patrick Leahy, a
young 25-year-old Maryland native who works in the office of Senator
Fred Thompson. Patrick is afflicted with Leibers, one of the forms of
retinitis pigmentosa.
Regardless of the debilitating effects of these groups of diseases
that Patrick and Isaac are afflicted with, they are both successful
young men who make us proud of their accomplishments and of their
unwavering optimism.
I would like to thank Isaac, Doria, Ilana, Patrick and all Americans
who are dealing every day with these diseases. We want to offer them
additional hope for a future in which we can soon eradicate retinal
degenerative diseases.
Research scientists at the Foundation Fighting Blindness are making
significant and exciting advances in the fight against retinal
degenerative diseases. The most solid advances have been in the
discovery of several new genes whose mutations cause retinal
degenerations. These discoveries are critical, because they allow us to
come closer to understanding the causes of these diseases and how one
day doctors will be able to repair these genetic mutations.
There have been significant discoveries in the areas of molecular
engineering and gene therapy. There have been significant advances made
in the lab with vectors which are modified viruses that transport
normal replacement genes into cells to help them function. This past
year, there was significant improvement in the new generation of
vectors which have the potential of being safer and more effective.
In the area of retinal transplantations, animals tested in labs with
pigment cell transplantation proved that such procedures can
effectively delay the degenerative process.
These tests must now be taken to the clinical trial level where we
can find out their effectiveness on humans. This is why it is very
critical to promote educational research.
Our prayers are with the Lidsky family and with all of those who are
similarly affected.
____________________